Search

Your search keyword '"Schmidt, Warren"' showing total 382 results
Start Over Author "Schmidt, Warren"
382 results on '"Schmidt, Warren"'

51. The Fact-Finding Conference: What It Is, When to Use It, How to Plan and Conduct It. Adult Education Monographs: 1.

Author

Adult Education Association of U.S.A., Washington, DC., Schmidt, Warren H., and Beckhard, Richard

Abstract

This manual describes the fact-finding conference and provides guidelines for determining when to use one, for planning one, and for conducting one. Defined first are various types of conferences, including the information-giving conference, the problem-solving or decision-making conference, the information-exchange conference, and the fact-finding conference. The role of fact-finding conferences in a national adult education project is examined. Following a discussion of various features of the fact-finding conference, guidelines are set forth for implementing the various phases of it, including initial planning; program development; final preparation; conducting the conference; and reporting, appraisal, and followup. A sample agenda and sample report-form questions are provided. Also analyzed is the role of the conference consultant. (MN)

Published
1956

60. Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Author

Schmidt, Warren and Kayali,Zeid

Subjects
Pharmacogenomics and Personalized Medicine
Abstract

Zeid Kayali,1 Warren N Schmidt2,3 1Division of Gastroenterology and Hepatology, University of Southern California, Los Angeles, CA, USA; 2Department of Internal Medicine and Research Service, Veterans Affairs Medical Center, Iowa City, IA, USA; 3Roy G and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA, USA Abstract: Chronic Hepatitis C virus (HCV) infection is the leading cause of advanced liver disease worldwide. The virus successfully evades host immune detection and for many years has hampered efforts to find a safe, uncomplicated, and reliable oral antiviral therapy. Initially, interferon and ribavirin therapy was the treatment standard of care, but it offered limited performance across the wide spectrum of HCV disease and was fraught with excessive and often limiting side effects. Sofosbuvir (SOF) is a potent first-in-class nucleoside inhibitor that has recently been approved for treatment of HCV. The drug has low toxicity, a high resistance barrier, and minimal drug interactions with other HCV direct-acting antiviral agents such as protease inhibitors or anti-NS5A agents. SOF is safe and can be used across different viral genotypes, disease stages, and special patient groups, such as those coinfected with human immunodeficiency virus. When used in combination with ribavirin or another direct-acting antiviral agent, SOF has revolutionized the HCV treatment spectrum and set the stage for nearly universal HCV antiviral therapy. More so than any other anti-HCV drug developed to date, SOF offers the widest applicability for all infected patients, and new regimens will be tailored to maximize performance. Keywords: Hepatitis C virus, sofosbuvir, polymerase inhibitors, interferon-free treatment

Published
2014

62. Shared Values Make a Difference: An Empirical Test of Corporate Culture.

Author

Posner, Barry Z., Kouzes, James M., and Schmidt, Warren H.

Subjects
CORPORATE culture, SOCIOLOGY of corporations, PERSONNEL management, ORGANIZATIONAL behavior, ORGANIZATIONAL effectiveness, MANAGEMENT styles, INDUSTRIAL management, ORGANIZATIONAL goals, PROFESSIONAL relationships, CULTURAL values
Abstract

Is the recent popular management literature on corporate culture and cultural values just a passing fad or is it highlighting some fundamental organizational realities? The results from a recent nationwide survey of American managers shows, we are convinced, that clearly articulated organizational values do make a significant difference in the lives of employees, as well as in their organization's performance. This article is an effort to integrate this broad-based data on individual managers' values with the reported experience of successful organizations that pay careful attention to their culture. It also offers ideas on how human resource managers can facilitate the alignment of personal and organizational values. [ABSTRACT FROM AUTHOR]

Published
1985
Full Text
View/download PDF

63. DETERMINING MANAGERIAL STRATEGIES IN THE PUBLIC SECTOR: WHAT KIND OF PEOPLE ENTER THE PUBLIC AND PRIVATE SECTORS? AN UPDATED COMPARISON OF PERCEPTIONS, STEREOTYPES, AND VALUES.

Author

Posner, Barry Z. and Schmidt, Warren H.

Subjects
EMPLOYEE attitudes, PRIVATE sector, PUBLIC sector, BUSINESS enterprises, WORK environment, EMPLOYMENT
Abstract

The article presents a comparison of the perceptions of public and business employees. Many studies over the years have compared public sector employment with private sector employment. Within each sector strong negative stereotypes are generally expressed about counterparts in the other sector. Employees in each sector feel that while their jobs are difficult and important but at the same time feel that their counterparts in the other sector have it quite easy. Such beliefs have important social consequences. The negative stereotypes of government employees persists despite the evidence from several recent studies that there are no significant differences between managers in the public and private sectors on such critical dimensions as leadership styles, ability, personality role ambiguity and conflict, motivational orientation, work patterns or job characteristics. Other major source of potential differences between public and private sector management is in terms of situational, environmental, and organizational distinctions. The impact of the work environment as a contributing factor to public versus private sector employment choices, attitudes, and managerial strategies continues to warrant investigation.

Published
1982
Full Text
View/download PDF

65. Resolve disputes with 5 questions

Author

Schmidt, Warren H. and Hateley, BJ Gallagher

Subjects
Business, general
Abstract

You can't break through a negotiating stalemate or a dispute by yourself. You need your opponent to be equally involved. Here are five questions that can help you create a [...]

Published
2021

67. A Peacock in the Land of Penguins : A Fable about Creativity and Courage Ed. 4

Author

Gallagher, Bj, Schmidt, Warren, Gallagher, Bj, Gallagher, Bj, Schmidt, Warren, and Gallagher, Bj

Abstract

?This is a book for everyone who wishes to contribute their unique gifts to the world.? ?Archbishop Desmond Tutu, Nobel Peace Laureate This brand new edition of a classic, international bestseller continues to bring keen insight to an important topic?workforce diversity. Written in a charming, engaging style, it is a contemporary corporate fable?a tale for our times. This special 20th anniversary edition includes many new tips, tools, and strategies for peacocks and penguins alike?as well as an entirely new bonus parable. Through the story of Perry the Peacock and his fine feathered friends, authors Gallagher and Schmidt bring to life the challenges of birds of different feathers who struggle to be successful in the conformity-minded Land of Penguins. Their travails illuminate the challenges of creating a pluralistic corporate culture in which the talent, energy, and commitment of all employees are fully engaged. People who have new ideas that differ from business as usual are often ignored or criticized for the very thing that makes them valuable: their originality and creativity. This unique book helps organizations break out of "penguin thinking? in order to tap into and leverage the creativity of diversity. Learn how to cultivate an organizational culture in which new ideas can flourish and innovation can take flight.

Published
2015

69. ODER AUTORITÄR?

Author

TANNENBAUM, ROBERT and SCHMIDT, WARREN H.

Published
2019

70. How to choose a leadership pattern.

Author

Tannenbaum, Robert and Schmidt, Warren H.

Subjects
PUBLISHED reprints, LEADERSHIP, EXECUTIVE ability (Management), EXECUTIVES, INDUSTRIAL relations, INDUSTRIAL management, SUPERIOR-subordinate relationship, BUSINESS enterprises, BUSINESS research, SUPERVISION of employees, ORGANIZATIONAL effectiveness
Abstract

Since its publication in HBR's March-April 1958 issue, this article has had such impact and popularity as to warrant its choice as an "HBR Classic." Mr. Tannenbaum and Mr. Schmidt succeeded in capturing in a few succinct pages the main ideas involved in the question of how a manager should lead his organization. For this publication, the authors have written a commentary, in which they look at their article from a 15-year perspective (see page 166). [ABSTRACT FROM AUTHOR]

Published
1973

71. Crises in a developing organization.

Author

Lippitt, Gordon L. and Schmidt, Warren H.

Subjects
INDUSTRIAL management, PERSONALITY development, MANAGEMENT
Abstract

Examines the application of certain personality development theories to the creation, growth, maturation, and decline of a business organization. Series of organizational crises facing a business organization as it goes through the stages of birth, youth, and maturity; Implications for executive development.

Published
1967

72. MANAGEMENT of DIFFERENCES.

Author

Schmidt, Warren H. and Tannenbaum, Robert

Subjects
CONFLICT management, INDIVIDUAL differences, INTERPERSONAL conflict, ORGANIZATIONAL sociology, COMMUNICATION styles, INTERGROUP relations, SUPERIOR-subordinate relationship, INTERPERSONAL relations, ORGANIZATIONAL communication, INFORMATION sharing, COMMUNICATION in management
Abstract

The article mentions the executive's role in managing disputes between subordinates who do not agree on a course of action, such as automation of a manual procedure in record-keeping. The first step is to diagnose the nature of their differences, which could be their viewpoint on facts, methods, goals, or values. Topics include the reasons for their different perspectives, the general solutions of avoidance, repression, sharpening into conflict and transformation into problem solving, five developmental stages in a dispute, managerial objectivity, and the disruptive effect of disputes.

Published
1960

73. How to Choose A Leadership Pattern.

Author

Tannenbaum, Robert and Schmidt, Warren H.

Subjects
LEADERSHIP, INDUSTRIAL management, SUPERIOR-subordinate relationship, MANAGEMENT styles, LEADERS, ORGANIZATIONAL effectiveness, EMPLOYEE participation in management, DECISION making, GROUP decision making, ORGANIZATIONAL sociology, DECENTRALIZATION in management, DECISION support systems, EXECUTIVE ability (Management)
Abstract

The article discusses a continuum of leadership behavior that is related to the degree of authority used by managers and the amount of freedom they permit subordinates during the decision-making process. Specific points on the continuum include the manager announcing a decision, selling a decision, presenting ideas and inviting questions, and defining limits and asking for a group's decision. Forces influencing executives are their value systems and confidence in subordinates, as well as the type of organization, pressure of time, and group effectiveness. Topics are the executive's responsibility when decision making is delegated to subordinates and the group's recognition of the boss's leadership style.

Published
1958

74. Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Author

Kayali,Zeid, Schmidt,Warren N, Kayali,Zeid, and Schmidt,Warren N

Abstract

Zeid Kayali,1 Warren N Schmidt2,3 1Division of Gastroenterology and Hepatology, University of Southern California, Los Angeles, CA, USA; 2Department of Internal Medicine and Research Service, Veterans Affairs Medical Center, Iowa City, IA, USA; 3Roy G and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA, USA Abstract: Chronic Hepatitis C virus (HCV) infection is the leading cause of advanced liver disease worldwide. The virus successfully evades host immune detection and for many years has hampered efforts to find a safe, uncomplicated, and reliable oral antiviral therapy. Initially, interferon and ribavirin therapy was the treatment standard of care, but it offered limited performance across the wide spectrum of HCV disease and was fraught with excessive and often limiting side effects. Sofosbuvir (SOF) is a potent first-in-class nucleoside inhibitor that has recently been approved for treatment of HCV. The drug has low toxicity, a high resistance barrier, and minimal drug interactions with other HCV direct-acting antiviral agents such as protease inhibitors or anti-NS5A agents. SOF is safe and can be used across different viral genotypes, disease stages, and special patient groups, such as those coinfected with human immunodeficiency virus. When used in combination with ribavirin or another direct-acting antiviral agent, SOF has revolutionized the HCV treatment spectrum and set the stage for nearly universal HCV antiviral therapy. More so than any other anti-HCV drug developed to date, SOF offers the widest applicability for all infected patients, and new regimens will be tailored to maximize performance. Keywords: Hepatitis C virus, sofosbuvir, polymerase inhibitors, interferon-free treatment

Published
2014

75. How to choose a leadership pattern

Author

Tannenbaum, Robert and Schmidt, Warren H.

Subjects
Leadership -- Practice, Business ethics -- Analysis, Executives -- Practice, Influence buying -- Usage, Bribery -- Usage, Business, Business, general
Published
1986

76. Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]

Author

Poynard, Thierry, primary, Munteanu, Mona, additional, Colombo, Massimo, additional, Bruix, Jordi, additional, Schiff, Eugene, additional, Terg, Ruben, additional, Flamm, Steven, additional, Moreno-Otero, Ricardo, additional, Carrilho, Flair, additional, Schmidt, Warren, additional, Berg, Thomas, additional, Mcgarrity, Thomas, additional, Heathcote, E. Jenny, additional, Gonçales, Fernando, additional, Diago, Moises, additional, Craxi, Antonio, additional, Silva, Marcelo, additional, Boparai, Navdeep, additional, Griffel, Louis, additional, Burroughs, Margaret, additional, Brass, Clifford, additional, and Albrecht, Janice, additional

Published
2013
Full Text
View/download PDF

78. FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program

Author

Poynard, Thierry, primary, Munteanu, Mona, additional, Colombo, Massimo, additional, Bruix, Jordi, additional, Schiff, Eugene, additional, Terg, Ruben, additional, Flamm, Steven, additional, Moreno-Otero, Ricardo, additional, Carrilho, Flair, additional, Schmidt, Warren, additional, Berg, Thomas, additional, Mcgarrity, Thomas, additional, Heathcote, E. Jenny, additional, Gonçales, Fernando, additional, Diago, Moises, additional, Craxi, Antonio, additional, Silva, Marcelo, additional, Boparai, Navdeep, additional, Griffel, Louis, additional, Burroughs, Margaret, additional, Brass, Clifford, additional, and Albrecht, Janice, additional

Published
2011
Full Text
View/download PDF

83. 831 FibroTest (Ft) Baseline Value Is An Independent Predictor of Early (EVR) and Sustained Virological Response (SVR) in Non-Responders Patients Re-Treated with Pegylated Interferon Alfa-2B (PEG-2B) and Ribavirin in EPIC3

Author

Poynard, Thierry, primary, Schiff, Eugene R., additional, Terg, Ruben, additional, Moreno-Otero, Ricardo, additional, Flamm, Steven L., additional, Schmidt, Warren N., additional, Berg, Thomas, additional, Goncales, Fernando L., additional, Heathcote, Jenny, additional, Diago, Moises, additional, McGarrity, Thomas, additional, Bedossa, Pierre, additional, Zhou, Honghong, additional, Mukhopadhyay, Pabak, additional, Griffel, Louis H., additional, Burroughs, Margaret, additional, Brass, Clifford A., additional, and Albrecht, Janice, additional

Published
2009
Full Text
View/download PDF

84. Reply

Author

Schmidt, Warren N., primary, Brown, Kyle E., additional, Luxon, Bruce A., additional, and Zhu, Zhaowen, additional

Published
2009
Full Text
View/download PDF

85. Managerial values across functions: a source of organizational problems

Author

Posner, Barry Z., Randolph, W. Alan, and Schmidt, Warren H.

Subjects
Organizational behavior -- Analysis, Organizational research -- Analysis, Management research -- Analysis, Education, Psychology and mental health
Abstract

Organizational difficulties which may have their roots in differences in managerial values across functions are examined. The values of managers in personnel, finance, manufacturing, and marketing were surveyed. The results show several significant differences in values that could lead to organizational problems. However, there were also many similarities across functions which could be used to reconcile these differences.

Published
1987

86. Women: the more committed managers?

Author

Powell, Gary N., Posner, Barry Z., and Schmidt, Warren H.

Subjects
Industrial management -- Social aspects, Executives -- Analysis, Women executives -- Analysis, Business, general
Published
1985

90. S1001 Clearance of HCV At 5 Year Follow-Up for Peginterferon Alfa-2b ± Ribavirin Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment

Author

Lindsay, Karen, primary, Manns, Michael P., additional, Gordon, Stuart C., additional, Pockros, Paul, additional, Haussinger, Dieter, additional, Hadziyannis, Stephanos J., additional, Schmidt, Warren N., additional, Jacobson, Ira M., additional, Barcena, Rafael, additional, Schiff, Eugene, additional, Shaikh, Obaid S., additional, Bacon, Bruce R., additional, Marcellin, Patrick, additional, Smith, Coleman I., additional, McHutchison, John G., additional, Deng, Weipeng, additional, Pedicone, Lisa D., additional, and Albrecht, Janice, additional

Published
2008
Full Text
View/download PDF

92. S1000 Results from the Epic3 Program: Platelet Counts Are Strong Predictors of Sustained Viral Response (SVR) in the RE-Treatment of Previous Interferon/Ribavirin Non-Responders (Nr)

Author

Poynard, Thierry, primary, Schiff, Eugene, additional, Terg, Ruben, additional, Moreno-Otero, Ricardo, additional, Flamm, Steven L., additional, Schmidt, Warren N., additional, Berg, Thomas, additional, Goncales, Fernando L., additional, Heathcote, Jenny, additional, Diago, Moises, additional, McGarrity, Thomas J., additional, Bedossa, Pierre, additional, Deng, Weipeng, additional, Mukhopadhyay, Pabak, additional, Griffel, Louis H., additional, Burroughs, Margaret, additional, Brass, Clifford A., additional, and Albrecht, Janice, additional

Published
2008
Full Text
View/download PDF

94. Older Donor Livers Show Early Severe Histological Activity, Fibrosis, and Graft Failure After Liver Transplantation for Hepatitis C

Author

Rayhill, Stephen C., primary, Wu, You Min, additional, Katz, Daniel A., additional, Voigt, Michael D., additional, LaBrecque, Douglas R., additional, Kirby, Patricia A., additional, Mitros, Frank A., additional, Kalil, Roberto S., additional, Miller, Rachel A., additional, Stolpen, Alan H., additional, and Schmidt, Warren N., additional

Published
2007
Full Text
View/download PDF

95. THE LONG REACH OF THE LOG CABIN COLLEGE.

Author

Schmidt, Warren R.

Abstract

The article discusses the lives of the 11 students who were in the first class of the Log Cabin College, the first college for Lutheran Church–Missouri Synod including Lydia Buenger, Christoph Loeber and Theodor Schubert.

Published
2015

96. Finally sofosbuvir: an oral anti-HCV drug with wide performance capability.

Author

Kayali, Zeid and Schmidt, Warren N.

Subjects
PERFORMANCE, DRUGS, DISEASES, PATIENTS, RIBAVIRIN
Abstract

Chronic Hepatitis C virus (HCV) infection is the leading cause of advanced liver disease worldwide. The virus successfully evades host immune detection and for many years has hampered efforts to find a safe, uncomplicated, and reliable oral antiviral therapy. Initially, interferon and ribavirin therapy was the treatment standard of care, but it offered limited performance across the wide spectrum of HCV disease and was fraught with excessive and often limiting side effects. Sofosbuvir (SOF) is a potent first-in-class nucleoside inhibitor that has recently been approved for treatment of HCV. The drug has low toxicity, a high resistance barrier, and minimal drug interactions with other HCV direct-acting antiviral agents such as protease inhibitors or anti-NS5A agents. SOF is safe and can be used across different viral genotypes, disease stages, and special patient groups, such as those coinfected with human immunodeficiency virus. When used in combination with ribavirin or another direct-acting antiviral agent, SOF has revolutionized the HCV treatment spectrum and set the stage for nearly universal HCV antiviral therapy. More so than any other anti-HCV drug developed to date, SOF offers the widest applicability for all infected patients, and new regimens will be tailored to maximize performance. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

98. Positive Serum Cryoglobulin Is Associated with Worse Outcome after Liver Transplantation for Chronic Hepatitis C

Author

Rayhill, Stephen C., primary, Kirby, Patricia A., additional, Voigt, Michael D., additional, La Brecque, Douglas R., additional, Lutz, Charles T., additional, Katz, Daniel A., additional, Mitros, Frank A., additional, Kalil, Roberto S., additional, Miller, Rachel A., additional, Stolpen, Alan H., additional, Heisey, Dennis, additional, Wu, You Min, additional, and Schmidt, Warren N., additional

Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results